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Depression is a disorder that can affect every aspect of one's life, ranging from
physical health issues to interpersonal relationship difficulties. Therefore, it is imperative
that the depressive symptoms of college students be identified, evaluated, and treated.
Self-report measures are a common technique to identify depressive symptomatology in
individuals and assist in diagnosis and treatment. Existing measures are often used as a
criterion by which to validate the psychometric properties and effectiveness of newly
designed, self-report measures. The purpose of this investigation was to explore the
concurrent validity of a newly published self-report measure of depression, the Clinical
Assessment of Depression (CAD; Bracken & Howell, 2004) with an existing measure,
the Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, & Brown, 1996).
The sample used for this investigation consisted of 125 college students (38 males and 87
females) ranging in age from 18 to 52 years. Internal consistencies for the sample were
computed for the BDI-II and the CAD and were found to be in the acceptable range with
computed coefficient alphas from r - .87 to .97. Significant, moderate to strong positive
correlations were found between the CAD total score and the CAD subscales with the
BDI-II total score and ranged from .55 to .97. This study also investigated gender
differences on both measures. Independent f-tests were computed and found no
significant difference between male and female mean scores on either the CAD or the
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BDI-II. Classification consistency between the CAD diagnosis of depression and the
BDI-II diagnosis of depression using the BDI-II as the criterion was 82%. The measures
have high consistency when identifying individuals as falling within a clinically
significant diagnostic category of depression. Overall, results indicate that the CAD is a
valid measure of depressive symptomatology in college students.
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Introduction
Depression is frequently referred to as the "common cold" of psychological
disorders as it is a common complaint that brings individuals in for psychological
treatment. Kessler et al. (2003) compiled prevalence rates from several large
epidemiological studies estimating the prevalence rate for major depressive disorder.
They found the prevalence rate to be approximately 16% across the lifespan and 6.5% in
the last 10 months. Kessler et al. (2003) further substantiated that women are twice as
likely to have mood disorders as men. Since depression is a common, frequently noted
psychological disorder, it is important to assess the nature and severity of depression in
order to appropriately treat the disorder.
Assessment of psychological disorders, such as depression, typically involves the
use of interviews and standardized instruments (Camara, Nathan, & Puente, 2000).
When new standardized measures are developed, it is important to determine their
effectiveness relative to existing measures. The Clinical Assessment of Depression
(CAD; Bracken & Howell, 2004) is a newly published measure that purports to assess
depression across the lifespan. Of interest to this study will be the CAD's ability to
assess and identify college aged individuals' symptoms of depression relative to an
existing measure in the field.
The following literature review will provide a rationale and purpose for
investigating the validity of the CAD. First, an overview of depression in college
students will be provided, along with a discussion of gender differences in depression.
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The diagnostic criteria for unipolor mood disorders will be provided as a basis for
understanding the assessment of depression. Last, a discussion of the CAD and rationale
for selection of the criterion measure, the Beck Depression Inventory-II (BDI-II; Beck,
Steer, & Brown, 1996), will provide a basis for the research questions for this study.

Review of Literature
Depression in College Students
There are approximately 19 million American adults affected annually by
depression, and college students are not exempt from the disorder. Nearly 10 percent of
college students arrive on campus with a history and/or diagnosis of depression. Further,
13 percent of female college students have a history of this disorder (National Mental
Health Association [NMHA], 2004; UMICH Health System, 2003). Typically the onset
of depression occurs between the ages of 15 and 19 years, and depression is frequently
comorbid with other disorders (UMICH Health System, 2003). Blazer, Kessler,
McGonagle, and Swartz (1994) found that the age groups of 15-to 24-year-olds and 35-to
44-year-olds were more likely than older individuals to have comorbid depression with
such psychiatric conditions as phobia, manic episode, nonaffective psychosis, generalized
anxiety disorder, panic disorder, or substance abuse or dependence.
College students experience similar symptoms as other adults who have
depression, but more specifically they experience pleasure and mood problems, tend to
withdraw from friends and activities that were once considered enjoyable, and have
difficulty performing academically. In addition, they experience problems concentrating,
feelings of being overwhelmed, and changes in appetite and sleep patterns. Because of
the physical distance between college students and their parents, as well as parents'
possible reluctance to disturb their child's newfound independence by asking about
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her or his well-being, it is often a student's friend, roommate, or residence hall advisor
who is the first to become aware of these behavior changes (UMICH Health System,
2003).
Undiagnosed and untreated depression can have an adverse impact on college
students, such as hindering one's ability to work, socialize, achieve academically, and
enjoy life in general. It can also lead to suicide. In 1998, suicide was the third leading
cause of death for those ages 15 to 24 and the second leading cause of death for college
students (NMHA, 2004). Therefore, the non-identification of depression can lead to
serious, and sometimes life-threatening, consequences.
Gender and Depression
When examining the prevalence rates of depression by gender, females are noted
to experience depressive moods nearly twice as frequently as males (American
Psychiatric Association [APA], 2000; Blazer et al., 1994; Kelly, Kelly, Brown, & Kelly,
1999; Kessler, McGonagle, Nelson et al., 1994; Klerman, 1988; NIMH, 2000; Weissman
et al., 1993). Ratios as high as 3:1 have been noted by some researchers (Klerman &
Weissman, 1989; Wetzel, 1994). Females have a higher lifetime prevalence rate for
major depression and dysthymia than males. Specifically, Weissman et al. (1993) found
females to have a higher rate of major depression (8% compared to 3.5%) than males, as
well as a higher rate of dysthymia (5.4% compared to 2.6%) in the United States. The
Cross-National Collaborative Group (Weissman et al., 1996) assessed depression rates in
10 countries and found that rates of major depression were higher for females than males
in every country, although the ratio varied from 1.6:1 in Beirut and Taiwan to 3.1:1 in
West Germany. Although research from Kessler, McGonagle, Zhao et al. (1994)
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supports the consensus regarding higher rates of depression in females compared to
males, it indicates that males ages 20 to 30 experience a higher rate of depression than
females. Although there is some variability among studies regarding the prevalence of
depression in females in comparison to males, the findings that females experience
depressive moods nearly twice as often as males appear to be reliable and stable.
The prevalence rate of depression not only varies between genders but it also
varies across ages. Depression occurs more frequently in younger individuals, beginning
in early adolescence, than older individuals (Reinherz, Frost, and Pakiz, 1991).
According to Cyranowski, Frank, Young, and Shear (2000), there is a general increase in
rates of depression for adolescent girls ages 11 to 13. By the age of 15, females are twice
as likely to have experienced a depressive episode as males. Although the reasons for the
higher rate of depression in females are unclear, some suggestions are provided to
account for this variability between genders. According to the NMHI study (1997), some
possible reasons for the higher prevalence rates are that females, in general, may be more
willing to seek help than males and therefore have a higher number of entries in the
depression database. Biological differences between females and males may also play a
role. An updated NIMH (2000) report suggests that hormonal changes associated with
women's menstrual cycle, pregnancy, and the postpartum period may be related to the
higher rates of depression in females. Certain psychosocial factors, such as different
social roles and less favorable economic opportunities, may contribute to this increased
rate. Also, the interpersonal relationships of females may play a role in their increased
risk of depression. For example, relationships seem to have a more profound effect on
the self-concept of females than on males. Furthermore, females are more prone to

experience distress from negative events in others' lives and place their needs secondary
to the needs of others (American Psychological Association [APA], 2002). According to
the American Psychological Association (APA, 2002), the cognitive styles of females can
contribute to their increased susceptibility to depression. For example, a ruminative
cognitive style, which is associated with severe and longer episodes of depression and
more commonly seen in females than males, is the repetitive focus on the symptoms,
causes, and consequences of distress. Breslau, Schultz, and Peterson (1995) suggest that
the increased rate of anxiety found in females earlier in life in comparison to males may
also play a role in the higher risk of female depression.
While females are twice as likely to experience depression in comparison to
males, other findings suggest that females report more depressive symptoms and greater
severity of depressive symptoms than males (e.g., Baron & Campbell; 1993, Casper,
Belanoff, & Offer, 1996; Kelly et al., 1999). Kelly et al. (1999) performed a study with
college-age participants and found a significant main effect for gender, F(3,138) = 2.69,
p < .05, with females scoring higher than males. In a study comparing female and male
mean scores on the Reynolds Adolescent Depression Scale (RADS) and the Beck
Depression Inventory (BDI), Baron and Campbell (1993) found that females have higher
mean scores on discriminating items. A study performed by Casper et al. (1996) also
found that females reported higher levels of depression than males across race.
According to Bailey, Wolfe, and Wolfe (1996), Caucasian females report significantly
higher levels of depression than either African-American or Caucasian males. These
findings support the view that females, in general, report more depressive symptoms than
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males. These gender differences in severity of rating may be due to previously
mentioned factors such as hormones, psychosocial issues, and coping styles.
Diagnostic

Criteria

For a young adult to be diagnosed with depression, specific criteria of the
Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision (DSMIV-TR; APA, 2000) must be met. There are three types of unipolar depressive disorders
described in the DSM-IV-TR: (a) Major Depressive Disorder, (b) Dysthymic Disorder,
and (c) Depressive Disorder Not Otherwise Specified.
Major Depressive Disorder, a severe form of unipolar depressive disorder, is
characterized by one or more major depressive episodes. These episodes last for at least
two weeks and consist of depressed mood and loss of interest in daily activities. To be
diagnosed with Major Depressive Disorder under the DSM-IV-TR criteria, one must also
have at least five or more of the following symptoms: "change in weight and/or appetite,
sleep, and psychomotor activity; decreased energy; feelings of worthlessness or guilt;
inability to concentrate or make decisions; or frequent thoughts of death and suicide
ideation" (APA, 2000, p. 356).
The second form of unipolar depressive disorder, Dysthymic Disorder, is
considered to have similar yet less severe symptoms than those of Major Depressive
Disorder. Individuals with this disorder are chronically depressed most days for at least
two years. Reported as feeling "down in the dumps," individuals diagnosed with this
disorder must meet at least three of the following symptoms during these depressed mood
states, according to DSM-IV-TR criteria: "poor appetite and/or overeating; insomnia
and/or hypersomnia; low energy and/or fatigue; low self-esteem; poor concentration
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and/or difficulty making decisions; or feelings of hopelessness" (APA, 2000, p. 374).
Although Dysthymic Disorder is typically considered less severe than Major Depressive
Disorder, a longitudinal study performed by Klein and Schwartz (2000) reported that
patients with Dysthymia had more severe mood symptoms, were more likely to make
suicide attempts, were more likely to be hospitalized, and had more functional
impairments than those patients with Major Depressive Disorder.
The third form of unipolar depression, Depressive Disorder Not Otherwise
Specified, is typically used when a disorder with depressive characteristics does not meet
the DSM-IV-TR criteria for major depression or dysthymia. An example of Depressive
Disorder Not Otherwise Specified is minor depression in which the depressive episodes
last at least two weeks but less than five symptoms are present from the criterion list for
major depression (APA, 2000).
Depression is diagnosed from observations or self-reports of at least 5 of the 9
behavioral indicators included in the diagnostic categories. Behavioral indicators of
depression cover a wide range of cognitive, affective, and physical symptoms. Because
of the variability and severity of depression, it is important that instruments used to
measure depression adequately cover the range of symptoms evident in depression, along
with being valid and reliable measures.
Self-Report Measures of Depression
A diagnosis of Major Depression, Dysthymia, and Depressive Disorder Not
Otherwise Specified is given after a comprehensive assessment is performed that would
determine the individual's symptoms and behavior patterns. In addition to observations
and oral reports, self-report scales are frequently used in the process of a comprehensive
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psychological assessment and are the focus of this investigation. Self-report measures
give the individual the opportunity to report her or his internal emotions, thoughts, and
feelings. The individual can provide more direct, first-hand information regarding her or
his internal state which may offer more insight about her or his personal experience with
depression than a third party's observations of symptoms and behaviors.
Self-report measures, which are typically norm referenced instruments, are
designed in such a way that the individual responds to a series of questions concerning
her or his social and/or emotional behavior, and these responses are then compared to a
population sample. It has been suggested by Martin (1988) that in order for a self-report
measure to be considered objective, it must have adequate test-retest reliability,
standardized procedures, adequate validity, and provide normative data for comparison.
One standardized, self-report measure frequently used to assess depression is the
Beck Depression Inventory which is currently in its second edition. It was originally
published in 1961 (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and underwent
amendments in 1979 and was most recently revised as the BDI-II (Beck, Steer, & Brown,
1996). This self-report measure of depression is one of the 50 most frequently used
psychological tests used by clinical and neuropsychologists, according to a national study
by Camara, Nathan, and Puente (2000).
The BDI-II is a 21-item, self-report measure that assesses the severity of
depression in individuals aged 13 years and older. The current version was modified to
assess symptoms which correspond with those of the American Psychiatric Association's
(APA) Diagnostic and Statistical Manual of Mental Disorders-Fourth

Edition (DSM-IV;

1994) criteria for diagnosing depressive disorders. The BDI-II omitted four previous
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items (Weight Loss, Body Image Change, Somatic Preoccupation, and Work Difficulty)
and replaced them with four new items (Agitation, Worthlessness, Concentration
Difficulty, and Loss of Energy). This change was made to address symptoms typical of
severe depression or depression which may require hospitalization. Additional
modifications made to the BDI-II were the adjustment of two items to allow for
fluctuations in appetite and sleep, as well as the rewording of statements used in rating
other symptoms (Beck, Steer, & Brown, 1996).
The BDI-II is one of the most widely used measures among practitioners (Camara
et al., 2000). It takes approximately 5 to 10 minutes to complete and can be administered
individually or orally to participants with reading and/or concentration difficulties.
Participants are asked to select one of 4 statements for each of a group of 21 test items
that best describes how she or he has been feeling for the past two weeks, including the
day of the assessment. Items are rated on a 4-point scale, ranging from 0 to 3, and then
each rating is summed to derive a total score. The maximum total score of the BDI-II is
63. Total scores of 0 to 13 indicate "Minimal" depressive symptomatology, 14 to 19
represent "Mild" depressive symptomatology, "Moderate" depressive symptomatology is
represented by scores of 20 to 28, and total scores of 29 to 63 represent "Severe"
depressive symptomatology (Beck, Steer, & Brown, 1996). The manual recommends a
cutoff score of 17 for research purposes, which will be used in the present study.
Although the BDI-II assists in identifying the presence and degree of depressive
symptoms, the authors warn that it should not be used as a single, clinical diagnosis
instrument due to a variety of disorders, such as panic disorder and schizophrenia, that
may accompany depression (Beck, Steer, & Brown, 1996).
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According to Arbisi (2001), the BDI-II possesses several strengths. It is an easily
administered instrument with straightforward interpreted guidelines. The test manual is
well-written, offering the reader an abundance of information regarding norms, factor
structure, and nonparametric item-option characteristic curves for each item. The BDI-II
is built on a strong empirical foundation of almost 40 years of research to support the
effectiveness of earlier versions.
Statistics for the BDI-II indicate that it is a reliable and valid measure to assess
depressive symptoms (Beck, Steer & Brown, 1996; Osman, Kopper, Barrios, Gutierrez,
& Bagge, 2004; Storch, Roberti, & Roth, 1997). As mentioned, Martin (1988) suggests
specific criteria are necessary for a measure to be considered an objective tool. The BDIII has an established test-retest reliability of .93 (Arbisi, 2001; Beck, Steer, & Brown,
1996; Farmer, 2001). It has a specific, standardized procedure in which items are given
to individuals in a consistent manner, and normative data is used for comparison of an
individual's score to scores of a larger group. Furthermore, the validity of the BDI-II has
been well established (Beck, Steer, & Brown, 1996; Osman, 2004; Storch et al., 1997).
Convergent and discriminant validity of the BDI-II has been established by comparing it
to existing psychological measures, such as the Beck Hopelessness Scale (BHS) and the
Revised Hamilton Psychiatric Rating Scale for Depression (HRSD-R). The BDI-II was
found to correlate positively with both the BHS (.68) and the HRSD-R (.71). In general,
reviewers agree that the BDI-II is a psychometrically sound measure that has been
improved with its most recent version (Arbisi, 2001; Farmer, 2001).
Although the BDI-II is considered the 10th most frequently used test by clinical
psychologists who conduct assessment services (Camara et al., 2000) and is used as the
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criterion measure for this investigation, it does have some weaknesses. As with any selfreport measure, it is possible for an individual to exaggerate her or his presentation. The
BDI-II does not have a validity scale to gauge for the possible distortion of results
(Arbisi, 2001). Furthermore, normative samples of the clinical population (suburban and
urban sections of the Northeastern United States) and non-referred population (Canada)
were not stratified to be representative of the U.S. population (Arbisi, 2001; Farmer,
2001). The authors of the BDI-II also failed to examine the test items for gender bias
(Farmer, 2001). Despite these obvious disadvantages, reviewers generally agree that the
BDI-II is a psychometrically adequate measure that has been improved with its most
recent revision (Arbisi, 2001; Farmer, 2001).
The Clinical Assessment of Depression (CAD), developed by Bracken and
Howell (2004), is an instrument designed to measure depression in individuals between
the ages of 8 and 79 years using a single form. The CAD is a 50-item scale with a fouroption response (Strongly Disagree, Disagree, Strongly Agree, and Agree). The CAD
assesses depressive symptoms on four subscales: Depressed Mood, Anxiety/Worry,
Diminished Interest, and Cognitive and Physical Fatigue. Specifically, the developers
focused on obtaining a nationally representative standardization sample and developing
an instrument that would provide validity scales, as well as symptom-based scales that
were psychometrically sound. In addition, the developers of the CAD wanted to provide
a measure that could be used to assess depression across the lifespan.
The normative population of the CAD was stratified by age, gender, and
race/ethnicity according to the 2001 census data (Bracken & Howell, 2004). Sampling
was stratified geographically, although it oversampled the Midwest and undersampled the
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Northeast. Total score coefficient alpha reliabilities for the standardization sample range
from .96 to .97 across the age ranges. For the four scales, coefficient alpha reliabilities
range from .78 to .96 which generally exceed the .90 criterion proposed by Bracken
(1987) for scales used for diagnostic decision-making. The standard error of
measurement for the T scores ranges from 2 to 5. Reliability coefficients for gender and
ethnicity are reported to be strong from .82 and above. Test-retest intervals of 7 to 36
days and 1 to 51 days for child and adult samples respectively yielded a CAD Total Test
stability coefficients of .85 and .86, respectively. Confirmatory factor analyses of the
sample for three age groupings of CAD normative sample yielded a four-factor model
consistent with the test structure. Thus, the CAD appears to be an improvement over
existing measures of depression, psychometrically as well as conceptually and
pragmatically. Information from the test manual suggests that it is more statistically
sound than previous measures, theoretically more well-defined with the use of its four
subscales, and it is a brief tool that can be used for all ages.
Independent research has generally supported the findings of the authors of the
CAD. Bowers (2004) examined the relationship between the BDI-II and the CAD among
122 adolescents (22 clinical, 98 nonreferred) and found a significant positive correlation
coefficient of .77 between the total scores of the BDI-II and the CAD. Tinsley (2004)
found a significant positive correlation between the CAD and the Reynolds Adolescent
Depression Scale (RADS, r = .88). Classification consistency between the CAD and the
BDI-II was 82% and between the CAD and the RADS was 83% for the total sample.
Coefficient alpha for the CAD for Bowers and Tinsley's sample was strong, r = .98, with
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item corrected correlations ranging from .81 to .88 for the subscales (Jones, Tinsley &
Bowers, 2005).
In summary, both the CAD and the BDI-II are adequate measures of depression;
however, the CAD appears to have a more superior and stratified sampling population
and demonstrates a sound factor structure for each scale. Although the BDI-II does have
weaknesses, it is the most frequently used measure to assess depressive symptoms and,
therefore, is a reasonable measure to use for comparison.
Purpose of Present

Investigation

Depression is a high incidence, psychological disorder that can cause an increased
risk for health and interpersonal problems. Although this disorder is found in both males
and females, research supports that females experience depressive moods twice as often
as males (APA, 2000; Blazer et al., 1994; Kelly et al., 1999; Kessler, McGonagle, Nelson
et al., 1994; Klerman, 1988; NIMH, 2000; Weissman et al., 1993). Further, studies have
shown that not only do females report more depressive symptoms than males but they
have a greater severity of depressive symptoms, as well (e.g., Baron & Campbell, 1993;
Casper, Belanoff, & Offer, 1996; Kelly et al., 1999). Self-report measures are essential
tools used to assess depression and aid in the diagnosis and treatment of this often
crippling disorder. One way to judge a new measure is to compare it to an existing
measure which can validate its usefulness and psychometric properties. The Standards
for Educational and Psychological Testing (AERA, APA, & NCME, 1999) recommend
that this comparison occur prior to the new measure's use in the field. As previously
discussed, the BDI-II is a psychometrically adequate and frequently used measure to
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assess depression. Therefore, it is reasonable to use the BDI-II as the criterion measure
to evaluate a new, similar measure-CAD.
This investigation explored the convergent validity of a newly published selfreport measure of depression , the Clinical Assessment of Depression (CAD),with an
existing measure, the Beck Depression Inventory-Second Edition (BDI-II). Along with
concurrent validity, gender differences in scores obtained and classification efficacy of
the CAD were explored. Specific hypotheses for this investigation were as follows:
1.

A significant positive relationship will be found between the ratings

obtained on the CAD and the BDI-II for a college population for the total scores on each
measure and each subscale of the CAD with the total score of the BDI-II.
2.

Higher mean scores will be obtained by females than males on both

measures. High classification efficacy is defined as classification agreement between the
BDI-II and the CAD equal to or greater than 80 percent.
3.
measure.

Classification efficacy will be high using the BDI-II as the criterion

Method
Participants
The sample consisted of 125 college students (38 males and 87 females) ages 18
to 52 from a south central Kentucky university enrolled in undergraduate psychology
courses in which instructors offered alternative methods for obtaining extra credit. The
mean age of this sample was 22, and it consisted of 110 Caucasians, 8 African
Americans, 1 Asian, and 6 Other. The sample also consisted of individuals with a
previous diagnosis of depression (13), comorbid depression (12), or no previous
diagnosis (105). Independent samples t tests were used to determine if the number of
individuals with a prior diagnosis was influencing or biasing the sample. No significant
difference was found on either of the measures between those with a diagnosis and those
without a diagnosis of depression (BDI-II t(125) = 2.153, p = .06; CAD t (125) = 1.943,
p = .06). Therefore, the participants of this study were viewed as one sample, rather than
placing them into diagnosed and non-diagnosed groups. Data on the BDI-II from five
female participants were incomplete and had to be excluded from the analyses of this
study.
Instruments
Demographic Form. A demographic form was used to track gender, race, age,
and history of depression for the sample (see Appendix A). The form also requested
contact information for each participant. The latter information was obtained in case
responses indicated a possibility of harm to self.
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Beck Depression Inventory-Second Edition (BDI-II). The BDI-II is a 21-item, self-report
inventory that measures symptoms of depression. The current edition is considered to be
more psychomentrically improved over the previous editions ( Arbisi, 2001; Farmer,
2001). The reliability of the BDI-II has been shown to be adequate with both clinical and
nonclinical populations. Internal consistencies for clinical and nonclinical populations
fall within the .89 and above range (Beck, Steer, Ball et al., 1996; Beck, Steer, Brown et
al., 1996; Jones, Tinsley & Bowers, 2005, Steer & Clark, 1997). Beck, Steer, and Brown
(1996) found a test-retest reliability coefficient of .91 over a one-week period.
Convergent and discriminant validity of the BDI-II was established by comparing
it to existing psychological measures and examining the factor structure of the scale.
Convergent validity with strong correlations was reported between the BDI-II with the
Revised Hamilton Psychiatric Rating Scale for Depression (r = .71) and the Beck
Depression Inventory (r = .93). Moderate correlations are noted with scales measuring the
related constructs of anxiety (Hamilton Rating Scale for Anxiety - Revised r = .47) and
hopelessness (Beck Hopelessness Scale r = .37; Beck, Steer, & Brown 1996). Farmer
(2001) reports that factor analysis has not yielded consistent findings with respect to the
factor structure for various populations (Beck, Steer & Garbin, 1988) and that the
measure is intended to assess one construct and should only be interpreted to assess one
construct.
Although the BDI-II is one of the most frequently used measures of depression
(Camara et al., 2000) and generally evidences sound psychometric properties, it does
evidence some weaknesses. Arbisi (2001) pointed out that the lack of a validity scale to
assess for distortions of responses and the lack of a stratified normative population were
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weaknesses of the BDI-II. Farmer (2001) indicated that the lack of analysis of the items
for gender bias is a significant problem. Despite these weaknesses, reviewers generally
agree that the BDI-II is a psychometrically adequate measure that has been improved
with its most recent revision (Arbisi, 2001; Farmer, 2001).
Clinical Assessment of Depression (CAD). The CAD (Bracken & Howell, 2004),
is a 50-item scale that takes approximately 10 minutes for completion. The age range for
this measure is 8 to 79 years. The CAD assesses depressive symptoms correlating with
DSM-IV criteria on four subscales: Depressed Mood, Anxiety/Worry, Diminished
Interest, and Cognitive and Physical Fatigue. The wording and content of items on all
four subscales are considered appropriate for use across the age span. The CAD was
designed as a comprehensive instrument that could be used across clinical, educational,
and research settings.
Due to the CAD's recent publication, it does not have the history and vast amount
of supportive research as the BDI-II; however, numerous subsample pilot studies and two
independent research investigations have provided some evidence of its psychometric
soundness. According to the Clinical Assessment of Depression Manual (Bracken &
Howell, 2004), its sound psychometric properties are substantiated by the use of a large,
diverse, national normative sample. Four normative age levels were used in the
development of this instrument (i.e., ages 8 to 11 years, 12 to 17 years, 18 to 25 years, 26
to 79 years) to determine its psychometric properties. The Total Scale score of the CAD
has coefficient alpha reliabilities that range from .96 to .97 and vary little by age, race,
and gender. The coefficient alphas for the subscales, which vary somewhat due to
sample size, are as follows: Depressed Mood, which evidences the highest reliability
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among the subscales, ranged from .95 to .96; Anxiety/Worry ranged from .83 to .86;
Diminished Interest ranged from .79 to .86; and Cognitive and Physical Fatigue ranged
from .82 to .87. In addition, the author reported that confirmatory factor analysis strongly
support the four subscale structure. Also, the test-retest reliability for the CAD's Total
Scale score ranged from .81 to .87 with a correlation between the CAD Total Scale score
and the BDI-II (.71) establishing concurrent validity.
Independent research was also performed to assist in the support of the CAD as a
sound measure. A study performed by Bowers (2004) examined the relationship between
the BDI-II and the CAD among clinical (n=23) and nonclinical (n=99) adolescents,
which indicated a correlation between the two measures of .77. Tinsley (2004), using the
same sample as Bowers (2004), analyzed the relationship between the CAD and the
Reynolds Adolescent Depression Scale (RADS). The correlation between the Total Scale
scores of the CAD and RADS (r = .88) was slightly higher than that of the CAD and
BDI-II, as well as the correlations found in both the combined clinical (r = .64) and
nonclinical (r = .82) adolescent groups used in a validity study with the normative
sample using the CAD and the RADS (Bracken & Howell, 2004). Tinsley's (2004)
findings were also consistent with Bower's (2004) results, reporting a classification
consistency of 83% for the total sample of both the CAD and the RADS. Jones, Tinsley,
and Bowers (2005) reported coefficient alpha of .98 for the CAD and item corrected
correlations ranging from .81 to .88 for Bowers (2004) and Tinsley's (2004) sample.
Based on data presented by the aforementioned studies, the CAD appears to be an
improvement over existing measures of depression. It has a representative normative
population and evidence of good reliability across gender, age, and race among both
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clinical and nonclinical groups. Construct validity is evidenced through confirmatory
factor analysis by its strong intercorrelations between each subscale and total scale
scores, as well as high correlations with existing measures (BDI-II and RADS).
Procedure
Participants were recruited from psychology courses at a south central Kentucky
University through the Student Study Board in which instructors offered alternative
methods for obtaining extra credit. The Student Study Board is an electronic
system which students can access and sign up for research study participation through a
website. Walk-in participants were also accepted for this study. Once the sign-up
process was completed, participants received information regarding specific time and
location for the study. At her or his designated time, each participant individually
received and was asked to complete a consent form (see Appendix B). Because data
collection for the present study overlapped with another investigation, the Beck Anxiety
Inventory (BAI) and the Brief Symptom Index (BSI), along with the BDI-II and the
CAD, were included in the packet. After consent was obtained, each participant received
a packet of forms (demographic form [Appendix A], CAD, BDI-II, BAI, and BSI) in
counter-balanced order to control for order effects. Upon completion of the four scales
and the demographic form, the participants were asked to return them to the investigator.
After the packet was returned to the investigator, each participant received a debriefing
statement (see Appendix C).
In order to maintain confidentiality, names were kept separate and did not appear
on the forms. A coding system was used for the forms to facilitate participant
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identification in the event any responses indicated a clinically significant level of
symptomatology. Seven participants were identified as having a clinically significant
response and were asked to meet with the primary investigator in private to discuss her or
his scores. The primary investigator provided information about depression and a list of
community resources for further assistance. All procedures for this study were approved
by Western Kentucky University's Human Subjects Review Board (see Appendix D).

Results
This study had three purposes: (a) to examine the relationship between the CAD
and the BDI-II, (b) to determine whether gender differences, specifically females having
higher mean scores, exist on both measures, and (c) to explore the classification
consistency using the BDI-II as the criterion measure. Additional analyses were
conducted to determine the reliability of each measure for this sample and to determine
the strength of the correlation of each CAD scale with the CAD Total score when the
scale items are partialed out.
Table 1 provides the mean score (M), the standard deviation (SD), and the
standard error of measurement ( S E M ) for the raw scores on each measure for the total
sample and for each gender. To examine the relationship between the BDI-II and CAD,
Pearson product-moment correlation coefficients were computed for the total raw scores
for each scale and the subscales of the CAD (i.e., Depressed Mood, Anxiety/Worry,
Diminished Interest, and Cognitive and Physical Fatigue) with the BDI-II total raw score.
Using the Bonferoni approach to control for Type I error across the 15 correlations, a p
value of less than .003 was established for significance. The results of the correlational
analyses are presented in Table 2. All of the 15 correlations were found to be positive
and statistically significant which supports the first hypothesis.
Additional analyses indicate that the CAD has item-total correlations within the
acceptable range with computed coefficient alphas from r = .87 to .97. Coefficient alpha
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Table 1
Descriptive Statistics for the Raw Scores on the CADa and the BDI-II1'

CAD

Sample

N

Male

38

Female

87

Total

a

125

M

SD

BDI-II

SEM

N

M

SD

SEM

93.79 25.55

4.15

38

11.32

8.72

1.42

86.11 21.80

2.34

87

8.26

6.56

.70

88.45

3.45

125

9.19

7.38

.66

23.17

Clinical Assessment of Depression. b Beck Depression Inventory-Second Edition.
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Table

3

Correlations of CAD" Total Score and Scales with BDI-Ilb Total Score, Coefficient
Alphas and Corrected item Total Correlations for the CAD".

Subscale

1

2

3

4

5

6

1. CAD Total Score

,97c

,95*(.84)

,89*(.82)

,82*(.79)

,90*(.84)

.68*

2. CAD, Depressed Mood

-

.96°

76*

.78*

.78*

.63*

.88°

68*

.82*

.62*

.90°

.69*

.55*

.87c

.63*

3. CAD, Anxiety/Worry
4. CAD, Diminished
Interest
5. CAD, Cognitive and

-

-

Physical Fatigue
6. BDI-II Total Score

-

Note. Values enclosed in parenthesis represent corrected item total correlations for the
CAD scale.
"Clinical Assessment of Depression. b Beck Depression Inventory-Second Edition.
c

Values represent coefficient alpha.

*p<.003

.89c
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for the BDI-II total score was acceptable but lower (r = .89). Corrected item total
correlation coefficients for each CAD scale were computed correlating each scale with
the other three CAD scales. All corrected item total correlations were strong ranging
from r = .79 to r = .84.
To determine whether gender differences were present, independent samples ttests were computed to compare mean scores of females to males for each measure.
Levene's Test for Equality of Variances was computed due to the unequal number of
participants in each group and found to be significant (p=.03) for the BDI-II. Therefore,
the Mest where variances are not assumed to be equal was used. The test for the BDI-II
was not significant, r(56) = 1.932, p = .06. The CAD results were also found to be
nonsignificant, ?(123) = 1.717, p = .089. The results indicate no significant gender
difference on either measure. Thus, hypothesis two was not supported.
To investigate classification efficacy of the CAD, the BDI-II was used as the
criterion measure. According to Bracken and Howell (2004), a T-score of 60 should be
used as the cut-off score to determine depressive symptomatology in the clinically
significant range. A raw score of 17 was used to indicate a clinically significant score on
the BDI-II as recommended in the manual (Beck, Steer, & Brown, 1996). A 2 x 2
contingency table was computed (Table 3) to compare depressed and non-depressed
classifications for the sample on each measure. The examination of the classifications of
both measures resulted in aX 2 - 22.97, (p < .000) and a classification agreement of 81%.
The CAD identified 13% of the cases as false positives, classifying individuals to be
depressed when they are not classified as depressed on the BDI-II, and 6% of the cases as
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Table 3
Total Sample Classification Table Between BDI-IF and CADbDiagnosis of Depression

CAD Classification

BDI-II Classification

Non-depressed

Depressed

Total

Non-depressed

Depressed

Total

70%

13%

83%

(n=87)

(n=16)

(n=103)

11%

17%

(n=8)

(n=14)

(n=22)

76%

24%

100%

(n=95)

(n=30)

(n=125)

6%

X2 = 22.97, p < .001
a

Clinical Assessment of Depression; depression classification based on T-score > 60.

b

Beck Depression Inventory-Second Edition; depression classification based on raw score

> 17.
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false negatives, finding individuals not depressed when they are experiencing depressive
symptoms, according to the BDI-II.

Discussion
The present researcher expected to find a significant positive correlation between
the CAD Total score and its subscales with the BDI-II. Total scores for each measure
were expected to yield moderate to high correlations between the two measures. In
addition, gender differences were to be examined for the CAD and the BDI-II.
Specifically, females were expected to have higher mean scores than males on both
measures. Further, classification efficacy was to be examined using the BDI-II as the
criterion measure.
To address the first purpose of determining the relationship between the CAD and
the BDI-II, Pearson product moment correlations were computed for the CAD total scale
score, CAD Depressed Mood scale, CAD Anxiety/Worry scale, CAD Diminished
Interest scale, CAD Cognitive and Physical Fatigue scale, and BDI-II total score. The
correlations between the BDI-II total score and the CAD total score and its four subscales
were found to be positive and significant ranging from .55 to .68, which were similar to
the findings of Bowers (r = .64 to .77; 2004) and Bracken and Howell (r =.42 to .73;
2004). According to Cohen's (1988) effect sizes to determine the strength of
correlations, all correlations were considered moderate, accounting for 30% to 46% of the
variance between the two measures. The weakest correlation (.55) was found between
the BDI-II total score and the CAD Diminished Interest scale score which was slightly
less than Bowers (2004) weakest correlation (.64) between the BDI-II total score and the
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CAD Diminished Interest scale score. Bracken and Howell (2004) reported a slightly
weaker correlation (.42) between the BDI-II total score and the CAD Anxiety/Worry
scale score. The current examination found the strongest correlation (.68) between the
BDI-II and the CAD total scores to be slightly lower than Bowers' (2004) and Bracken
and Howell's (2004) findings (.77 and .70, respectively).
The correlations between the CAD total score and its subscales were also found to
be positive and significant, ranging from .68 to .95. The weakest correlation (.68) was
found between the CAD Anxiety/Worry and Diminished Interest scale scores, while the
CAD total score and the CAD Depressed Mood scale score was found to be the strongest
correlation (.95). These findings are quite similar to those of Bracken and Howell (2004)
with CAD total score and subscale score correlations ranging from .68 to .95, as well.
Bowers (2004) produced slightly higher correlations ranging from .76 to .97. The
correlations of the current study were considered moderate to strong, accounting for
approximately 40% to 90% of the variance between the CAD total score and its subscale
scores. Further analyses computed corrected item total correlations between each CAD
scale and the other 3 CAD scales (Depressed Mood, Anxiety/Worry, Diminished Interest,
and Cognitive and Physical Fatigue) and found strong correlations, as well, ranging from
.79 to .84 indicating that each scale contributes similar, yet different information to the
total score. These findings are consistent with those of Jones, Tinsley, and Bowers
(2005) which reported corrected item total correlations between each CAD scale ranging
from .81 to .88. In general, these results are consistent with previous findings and
support the hypothesis that the CAD demonstrates strong concurrent validity with the
BDI-II.
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The reliability of the CAD and its subscales were found to be quite strong with
coefficient alphas ranging from .87 to .96. These results are consistent with Bowers'
(2004) findings of coefficient alphas ranging from .77 to .97 and Bracken and Howell's
findings (r = .76 to .90; 2004). The Depressed Mood subscale had the strongest
reliability (.96) with the overall total score, and the Cognitive and Physical Fatigue
subscale had the weakest reliability (.87) with the CAD total score. The strong reliability
between the CAD total score and its subscales indicate that each individual subscale
loads heavily on the overall total score which provides support that the CAD is a sound
measure that consistently measures associated constructs. The BDI-II, however, did not
fair as well regarding reliability. Inter-item analyses were conducted to see how well
each item loaded on the BDI-II total score and resulted in a coefficient alpha of .89.
Experts in the field recommend using measures with reliabilities above .90 for
diagnostic purposes (Bracken, 1987). The reliability of .89 for the BDI-II does not meet
this recommendation; however, the CAD meets this criterion for the Total, Depressed
Mood, and Diminished Interest scales. This higher reliability suggests that the CAD best
meets Bracken's (1987) criterion of .90 internal consistency for a measure used for
diagnostic purposes.
The second purpose of this study was to investigate whether gender differences
exist on both measures, specifically females obtaining a higher mean score than males.
Independent samples Mests were used to compute any mean gender differences of the
CAD and BDI-II. The r-test computed for the BDI-II and the CAD found no gender
differences in mean scores. Although results of this study do not support past research in
which females report more severe ratings of depressive symptoms than males, this

31
finding is consistent with normative data for the CAD which found no gender differences
(Bracken & Howell, 2004).
The final purpose of this study was to analyze the classification efficacy of the
CAD using the BDI-II as the criterion measure. Using a 2 x 2 contingency table, the
classification consistency for the total sample was found to be 81%. Although the hit rate
for the total sample was found to be high, 13% were identified as false positives and 6%
as false negatives. These findings were consistent with those of Bowers (2004) with a
total sample classification consistency of 82% between the CAD and the BDI-II (10%
identified as false positives and 8% identified as false negatives), as well as Tinsley's
(2004) report of classification consistency of 83% for the total sample of both the CAD
and the RADS. A false positive, which is a more conservative classification, occurred
when the BDI-II identified an individual as not depressed and the CAD identified that
individual as depressed. A false negative, which is a more liberal classification, occurred
when the BDI-II identified an individual as depressed and the CAD identified that
individual as not depressed. Although a false positive is still considered an error, it is
more preventative when diagnosing depression. Therefore the greater percentage of false
positive makes the CAD a more conservative measure than the BDI-II.
Limitations
Although pertinent information can be obtained from the current study, there are
limitations that may impact the interpretation of the results. For example, small sample
size, specifically in the male group, may have limited the findings of this study. An
external threat that may have affected data collection is the sole geographic region in
which data were collected for this study. The participants were recruited from a south
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central Kentucky university. Although the sample's ethnicity was representative of the
region (7% minority), it is not representative of the United States' population as a whole
and, therefore, may not be generalizable to other geographic regions.
Implications
Practical Implications.

The findings of this study have strong implications for

practitioners engaged in psychological assessment. Due to the high incidence rate of
depression, it is essential to have sound psychometric measures to assess this disorder,
which are limited in the field of psychology. The current study assists in providing data
that supports the validity of the CAD and provides support for the use of an additional
assessment resource which can be used to aid in the diagnosis and treatment of
depression. This study specifically provides information independent from the test
publisher regarding the validity of the CAD with college students. Because depression,
which has been reported to be on the rise in recent years (NMHA, 2004), can have such
an adverse impact on every aspect of one's life, it is imperative to have valid, reliable,
and standardized measures by which to assess this disorder for the proper identification
of depressive symptoms and effective treatment. Experts recommend that measures have
a reliability of .90 for diagnostic purposes. In a study using a college-age sample
performed by Beck et al. (1996), results indicated a coefficient alpha of .89. Although
this is considered a high internal consistency, it does not meet Bracken's (1987) criterion
for diagnostic purposes. While the BDI-II had reliability below the recommended .90
level for this sample as well, the CAD reached acceptability (alphawise) for classification
decisions for the total score and two of the four subscales. Furthermore, the results of
this study have significant implications for practitioners' longitudinal evaluation of
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clients. The CAD is designed to facilitate the identification of individuals across the
lifespan and should be considered a useful tool to monitor the progress of clients.
Because of this instrument's strong theoretical basis, addressed through the four
subscales, and broad age range, practitioners will be able to use information from this
single measure throughout the individual's treatment without the introduction of new,
possibly incompatible instruments.
Recommendations for future research. The current study investigated the
convergent validity between the CAD and the BDI-II, both designed to specifically
measure depressive symptoms. Future research may want to examine divergent validity
among various tools that measure a wider range of clinical symptoms including, but not
limited to, depression. Also, additional evidence of validity should be explored through
factor analysis which would further substantiate the subscale structure of the CAD. To
further explore gender differences of depression, future research containing a larger,
more equal sample size across gender that is pooled from a more generalizable setting
would be ideal for future research.
Also, this study focused on a college-age sample consisting of predominantly
Caucasian individuals in their early twenties. Further research should be conducted
across various races and ages to obtain additional information regarding depression and
how well the CAD assesses depression across the lifespan of individuals from different
ethnic groups.
Finally, further evidence of the CAD's validity should be explored by examining
a large, clinical population in comparison to a non-referred sample. By comparing a
clinical and non-referred population, information could be gathered to determine whether
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the CAD depicts those who have been diagnosed with depressive disorders as also
demonstrating depressive symptomatology.
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Demographic Form
Age:

years

Gender:

Race:

months

Male
Female
Caucasian
African American
Asian
Other

Level of Education
Freshman
Sophomore
Junior
Senior
Have you ever been diagnosed with a psychological disorder? Circle One
Yes
If yes, please respond to the following:
Who made the diagnosis?
Family Doctor
Counselor
Social Worker
Psychologist
Psychiatrist

No

What was your diagnosis?
Are you currently under treatment?

Check all that apply:

Therapy/Counseling
Medication

If you are not currently in treatment when did you end treatment? Year

Name:
Phone:
E-Mail Address

Appendix B
Consent Form
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INFORMED CONSENT
Social and Emotional Weil-Being Study
Project Title: Emotional Well-Being Study
Investigators: Elizabeth L. Jones, Ph.D., Shelley Hicks, and Carlie West
Department of Psychology, 745-4414
You are being asked to participate in a project conducted through Western Kentucky University
investigating the usefulness of 4 measures of social and emotional well-being used with young adults.
Please read the following information carefully. It describes the purpose of the study, the procedure to be
used, risks, and benefits of your participation and what will happen to the information that is collected from
you. If you agree to participate in this project, Western Kentucky University requires that you give your
signed agreement to participate in this project.
The investigator will explain to you in detail the purpose of the project, the procedures to be used, and the
potential benefits and possible risks of participation. You may ask him/her any questions you have to help
you understand the project. A basic explanation of the project is written below. Please read this
explanation and discuss with the researcher any questions you may have.
If you then decide to participate in the project, please sign on the last page of this form in the presence of
the person who explained the project to you. You should be given a copy of this form to keep.
1.
Nature and Purpose of the Project: The purpose of this study is to evaluate a new questionnaire
designed to assess social and emotional well-being in young adults.
2.
Explanation of Procedures: Upon your consent, you will be asked to complete a packet of 4
questionnaires concerning your thoughts, feelings, and emotions as they related to your day-to-day
functioning. It will take approximately 30 minutes to complete these 4 questionnaires.
3.
Discomfort and Risks: There are no physical risks involved in filling out the questionnaires.
However, answering the items may cause you to feel some emotional discomfort, due to the nature of the
questions asked.
4.
Benefits: You may be able to receive extra credit for you psychology courses, if you instructor
offers such credit (be sure to check with your instructor).
5.
Confidentiality: All information collected will be kept strictly confidential and will be accessible
only to the project staff. In addition, all names will be kept separate from the questionnaires. However, if
your responses to these questionnaires indicate that you may be of harm to yourself or to other people, the
researchers will immediately inform you.
6.
Refusal/Withdrawal: Refusal to participate in this study will have no effect on any future
services you may be entitled to from the University. Anyone who agrees to participate in this study is free
to withdraw from the study at any time with no penalty.
7.
Questions: Can be directed to the researchers collecting data or to Dr. Elizabeth Jones. Dr. Jones
can be reached in her office (260 TPH) during her office hours (see schedule on her door) or at (270)7454414.
You understand also that it is not possible to identify all potential risks in an experimental procedure, and
you believe that reasonable safeguards have been taken to minimize both the known and potential but
unknown risks.

Signature of Participant

Date

Witness

Date
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY
THE WESTERN KENTUCKY UNIVERSITY HUMAN SUBJECTS REVIEW BOARD
Dr. Phillip E. Myers, Human Protections Administrator
TELEPHONE: (270) 745-4652
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4-7

Debriefing
Thank you for participating in this research study. This study was designed to examine
the usefulness of a new measure of depression, the Clinical Assessment of Depression.
For example, does the Clinical Assessment of Depression measure depression as will as
other measures in the field such as the Beck Depression Inventory and the Brief
Symptom Index? If you would like a final copy of the research project, please contact
Dr. Elizabeth Jones at (270)745-4414, or at the Department of Psychology, Western
Kentucky University, 1 Big Red Way, Bowling Green, KY 42101. The final copies will
not be available until after December 1, 2005.
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WESTERN KENTUCKY UNIVERSITY
Human Subjects Review Board
Office of Sponsored Programs
106 Foundation Building
270-745-4652; Fax 270-745-4211
E-mail: Sean.Rubino@wku.edu
In future correspondence please refer to HS05-087, February 15, 2005
Dr. Elizabeth Jones
260 TPH
Department of Psychology
WKU
Dear Dr. Jones:
Your revision to your research project, "Validity of the Clinical Assessment of Depression," was reviewed
by the HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable; and that
(2) research procedures are consistent with a sound research design and do not expose the subjects to
unnecessary risk. Reviewers determined that: (1) benefits to subjects are considered along with the
importance of the topic and that outcomes are reasonable; (2) selection of subjects is equitable; and (3) the
purposes of the research and the research setting is amenable to subjects' welfare and producing desired
outcomes; that indications of coercion or prejudice are absent, and that participation is clearly voluntary.
1.

In addition, the IRB found that you need to orient participants as follows: (1) signed informed consent
is required; (2) Provision is made for collecting, using and storing data in a manner that protects the
safety and privacy of the subjects and the confidentiality of the data. (3) Appropriate safeguards are
included to protect the rights and welfare of the subjects.
This project is therefore approved at the Expedited Review Level until December 20, 2005.

2.

Please note that the institution is not responsible for any actions regarding this protocol before
approval. If you expand the project at a later date to use other instruments please re-apply. Copies of
your request for human subjects review, your application, and this approval, are maintained in the
Office of Sponsored Programs at the above address. Please report any changes to this approved
protocol to this office. A Continuing Review protocol will be sent to you in the future to determine the
status of the project.

Sinrprpl v

SeanRubino, M.P.A.
Compliance Manager
Office of Sponsored Programs
Western Kentucky University

cc: HS file number Jones HS05-087
cc: Shelley Hicks
cc: Carlie West

